5/20
07:44 am
fulc
Rating for FULC
Medium
Report
Rating for FULC
5/20
07:17 am
fulc
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $23.00 price target on the stock.
Low
Report
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $23.00 price target on the stock.
5/20
06:03 am
fulc
Fulcrum Therapeutics initiated with bullish view at Cantor Fitzgerald
Low
Report
Fulcrum Therapeutics initiated with bullish view at Cantor Fitzgerald
5/14
08:39 am
fulc
Rating for FULC
Low
Report
Rating for FULC
5/14
08:39 am
fulc
Rating for FULC
Low
Report
Rating for FULC
5/14
08:39 am
fulc
Rating for FULC
Low
Report
Rating for FULC
5/14
08:07 am
fulc
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock.
Medium
Report
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock.
5/14
05:20 am
fulc
Rating for FULC
Low
Report
Rating for FULC
5/14
05:20 am
fulc
Rating for FULC
Low
Report
Rating for FULC
5/13
04:20 pm
fulc
Rating for FULC
Low
Report
Rating for FULC
5/13
04:20 pm
fulc
Rating for FULC
Low
Report
Rating for FULC
5/13
04:20 pm
fulc
Rating for FULC
Low
Report
Rating for FULC